Similar with JQ1, non-benzodiazepine I-BET151 is a pan-BET inhibitor, which can exhibit significant anti-tumor activity in murine models of NUT midline carcinoma, multiple myeloma, MLL and ALL, lung cancer, and malignant brain tumor. This evidence concerns the gene DNER and acute lymphoblastic leukemia.